Reforming 340B to Serve the Interests of Patients, Not Institutions - PubMed (original) (raw)

Reforming 340B to Serve the Interests of Patients, Not Institutions

Anthony M DiGiorgio et al. JAMA Health Forum. 2024.

Free article

Erratum in

• Omitted Conflict of Interest Disclosures.
  [No authors listed] [No authors listed] JAMA Health Forum. 2024 Aug 2;5(8):e243106. doi: 10.1001/jamahealthforum.2024.3106. JAMA Health Forum. 2024. PMID: 39120970 Free PMC article. No abstract available.

No abstract available

Plain language summary

This Viewpoint discusses reforms to the 340B Drug Pricing Program to focus revenues from the program on lower-income and uninsured patients.

PubMed Disclaimer

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems